VAS
VRTX icon

Vestmark Advisory Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.9M Sell
8,763
-3,625
-29% -$1.61M 0.06% 254
2025
Q1
$6.01M Buy
12,388
+6,595
+114% +$3.2M 0.15% 176
2024
Q4
$2.33M Sell
5,793
-346
-6% -$139K 0.08% 237
2024
Q3
$2.86M Buy
6,139
+26
+0.4% +$12.1K 0.11% 207
2024
Q2
$2.87M Buy
6,113
+4,610
+307% +$2.16M 0.12% 188
2024
Q1
$628K Sell
1,503
-2
-0.1% -$836 0.03% 360
2023
Q4
$612K Sell
1,505
-164
-10% -$66.7K 0.03% 325
2023
Q3
$580K Sell
1,669
-15,332
-90% -$5.33M 0.04% 280
2023
Q2
$5.98M Sell
17,001
-219
-1% -$77.1K 0.23% 111
2023
Q1
$5.43M Sell
17,220
-734
-4% -$231K 0.24% 114
2022
Q4
$5.18M Sell
17,954
-204
-1% -$58.9K 0.25% 98
2022
Q3
$5.26M Sell
18,158
-591
-3% -$171K 0.29% 79
2022
Q2
$5.28M Sell
18,749
-1,024
-5% -$289K 0.3% 74
2022
Q1
$5.16M Sell
19,773
-209
-1% -$54.5K 0.29% 71
2021
Q4
$4.39M Sell
19,982
-357
-2% -$78.4K 0.25% 88
2021
Q3
$3.69M Sell
20,339
-400
-2% -$72.6K 0.25% 94
2021
Q2
$4.18M Buy
20,739
+1,197
+6% +$241K 0.3% 79
2021
Q1
$4.2M Buy
19,542
+4,009
+26% +$861K 0.37% 59
2020
Q4
$3.67M Buy
15,533
+1,712
+12% +$405K 0.41% 52
2020
Q3
$3.76M Buy
13,821
+2,128
+18% +$579K 0.51% 37
2020
Q2
$3.4M Buy
11,693
+817
+8% +$237K 0.53% 39
2020
Q1
$2.59M Sell
10,876
-530
-5% -$126K 0.51% 42
2019
Q4
$2.5M Sell
11,406
-239
-2% -$52.3K 0.51% 58
2019
Q3
$1.97M Sell
11,645
-309
-3% -$52.4K 0.32% 86
2019
Q2
$2.19M Buy
11,954
+97
+0.8% +$17.8K 0.38% 65
2019
Q1
$2.18M Buy
+11,857
New +$2.18M 0.39% 64